OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

9475	Companies
185456	Keywords
117803	Articles
99310	Press releases

Home
Companies
OXURION

BRIEF

published on 05/15/2025 at 18:05, 6 months 20 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/15/2025 at 18:00, 6 months 20 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion announces receipt of transparency notifications regarding share ownership by Atlas Special Opportunities II, LLC, crossing thresholds under and above 5% and 25%

Share Ownership Thresholds Oxurion Atlas Special Opportunities II Transparency Notifications
BRIEF

published on 05/12/2025 at 18:05, 6 months 23 days ago

Oxurion Reports Shares Threshold Crossings by Atlas Special Opportunities

Transparency Notification Atlas Special Opportunities Oxurion Shareholding Thresholds Retinal Disease Therapies
PRESS RELEASE

published on 05/12/2025 at 18:00, 6 months 23 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease

Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF

published on 05/09/2025 at 18:05, 6 months 26 days ago

Oxurion Increases Capital Following Convertible Bond Conversion

Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares
PRESS RELEASE

published on 05/09/2025 at 18:00, 6 months 26 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, resulting in EUR 100,000 capital increase, supporting innovative therapeutics development for vision preservation in elderly. Oxurion shares update post-capital increase

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Vision Preservation
BRIEF

published on 04/25/2025 at 18:35, 7 months 9 days ago

Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition

Acquisition Negotiations CRO Oxurion Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 7 months 9 days ago

Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025
Oxurion NV halts acquisition of French CRO, pursues deal with biometrics CRO to expand capabilities in clinical data management. Progress updates to follow

Acquisition CRO Oxurion NV Clinical Data Management Biometrics
BRIEF

published on 04/11/2025 at 20:05, 7 months 23 days ago

Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting

Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
PRESS RELEASE

published on 04/11/2025 at 20:05, 7 months 23 days ago

Publication Annual Report - Annual Shareholders' Meeting
Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease

Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease

Accesswire

Published on 12/05/2025 at 02:35, 11 hours 22 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 27 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 12 hours 57 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 52 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 57 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 11 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 57 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 57 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 51 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 57 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 12 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 57 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 12 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 13 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE